<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/60490ABB-1BA0-4FD0-93D5-2C3D306FD71D"><gtr:id>60490ABB-1BA0-4FD0-93D5-2C3D306FD71D</gtr:id><gtr:name>CN Bio Innovations Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F6FCF085-72B2-4574-A74D-D90199FA4BFD"><gtr:id>F6FCF085-72B2-4574-A74D-D90199FA4BFD</gtr:id><gtr:name>Abide Therapeutics</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BE5027A2-9A29-4322-AB89-41E0AF3BC9FF"><gtr:id>BE5027A2-9A29-4322-AB89-41E0AF3BC9FF</gtr:id><gtr:name>MedImmune</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/60490ABB-1BA0-4FD0-93D5-2C3D306FD71D"><gtr:id>60490ABB-1BA0-4FD0-93D5-2C3D306FD71D</gtr:id><gtr:name>CN Bio Innovations Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F6FCF085-72B2-4574-A74D-D90199FA4BFD"><gtr:id>F6FCF085-72B2-4574-A74D-D90199FA4BFD</gtr:id><gtr:name>Abide Therapeutics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BE5027A2-9A29-4322-AB89-41E0AF3BC9FF"><gtr:id>BE5027A2-9A29-4322-AB89-41E0AF3BC9FF</gtr:id><gtr:name>MedImmune</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/95DF1C05-09A0-412A-87F2-6D0A6175BFD7"><gtr:id>95DF1C05-09A0-412A-87F2-6D0A6175BFD7</gtr:id><gtr:firstName>Matthew</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Wood</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_14131"><gtr:id>5AE13CB2-644C-4B55-B412-74ACEC41DC0E</gtr:id><gtr:title>Proximity to Discovery - University of Oxford</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_14131</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The MRC Proximity to Discovery scheme awards universities funds to help develop new collaborations, and ways of exchanging knowledge and skills.&amp;nbsp; The awards can be used to support activities that promote the value of academic-industry partnership, and enhance academic and industry researchers? understanding of each other?s needs and capabilities.&amp;nbsp; This may be through people exchanges, creation of technology demonstrators, showcase events, commercialisation workshops and ?entrepreneurs in residence? schemes.&amp;nbsp; Such exchanges of knowledge and skills will boost the most fruitful collaborations between UK universities and life science companies.</gtr:technicalSummary><gtr:fund><gtr:end>2016-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>150000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>UCB Pharma</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UCB collaboration with Sansom &amp;amp; Stansfeld</gtr:description><gtr:id>02A2DF1F-3D94-426D-97B0-02CCD7A92BAE</gtr:id><gtr:impact>This has resulted in UCB supporting an additional iCASE studentship in my group.</gtr:impact><gtr:outcomeId>58c2bbcaf3e150.96613023-1</gtr:outcomeId><gtr:partnerContribution>Dr Zara Sands (UCB) spent time in my lab and worked alongside students &amp;amp; postdocs to familiarize herself with our methods for simulation of complex cell membranes</gtr:partnerContribution><gtr:piContribution>Dr Zara Sands (UCB) spent time in my lab and worked alongside students &amp;amp; postdocs to familiarize herself with our methods for simulation of complex cell membranes</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Abide Therapeutics</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Abide Therapeutics - Oxford Collaboration</gtr:description><gtr:id>E83B2F04-AB61-470E-90DA-2B035265AC17</gtr:id><gtr:impact>No publications yet. 
No patents arising.
There are other Abide - Oxford collaborations but these are separate to our own collaboration.</gtr:impact><gtr:outcomeId>58c6a7223088b3.17072958-1</gtr:outcomeId><gtr:partnerContribution>Processing of samples using activity-based protein profiling and lipidomics.
Expertise in the pharmacology of the endocannabinoid system.</gtr:partnerContribution><gtr:piContribution>Expertise in innate immunology in relation to the gut and inflammatory bowel disease. Preclinical work with human primary dendritic cells and colon tissue examining roles for the endocannabinoid system.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MedImmune</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MedImmune Cambridge</gtr:department><gtr:description>MedImmune Collaboration</gtr:description><gtr:id>20B24AF7-962A-4D8A-A15F-2F627D1932A0</gtr:id><gtr:impact>Data generation</gtr:impact><gtr:outcomeId>58c585bb0b9972.52839375-1</gtr:outcomeId><gtr:partnerContribution>Analysis of samples, data to be analysed and reported in publication</gtr:partnerContribution><gtr:piContribution>Scientific collaboration with MedImmune</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>CN Bio Innovations Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CN-Bio collaboration</gtr:description><gtr:id>8F3008B3-6531-4C97-B886-739B38964732</gtr:id><gtr:impact>Developing tools to study innate responses in the liver</gtr:impact><gtr:outcomeId>58c1a4d7c6d479.02562385-1</gtr:outcomeId><gtr:partnerContribution>Expertise and experiments in in vitro model</gtr:partnerContribution><gtr:piContribution>Analysis of innate responses in an in vitro hepatocyte model</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Molecular Haematology Unit seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BA0E40DC-95F2-4775-B63F-59A7F31BC7AA</gtr:id><gtr:impact>A talk regarding the work on single-cell systems biology carried out by the company to date. This sparked a good debate between the presenter and the audience.</gtr:impact><gtr:outcomeId>58c915d7ed93c3.49947622</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>OxAgeN - establishment of the Oxford Aging Network (L. Cox)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D49FF6F7-9E2C-4BB8-B15A-DBC482B61B6D</gtr:id><gtr:impact>Established a network of scientists and clinicians with an interest in ageing (research and clinical practice) to foster closer collaboration and accelerate discoveries from bench to clinic. Representatives from commercial organisations and third sector (U3A, Age UK) are also members.
Impact: decision to hold scientific conference on ageing in Oxford.</gtr:impact><gtr:outcomeId>56d3170b89dde7.93753941</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.imm.ox.ac.uk/ageing</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Engagement (Pint of Science)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DC2CEB59-95FB-4699-927E-52D6F24AF88C</gtr:id><gtr:impact>Pint of Science talks aim to deliver the most recent/exciting scientific advances to the general public in a relaxed and informal setting. It is a platform for the general public to ask questions about scientific research, to the researchers carrying out the experiments! The aim is to broaden public interest in- and access to- scientific discoveries and data. Date of event: May 17th 2017.</gtr:impact><gtr:outcomeId>58ca7fd03ee169.40294296</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://pintofscience.co.uk/events/oxford</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk, OxAgeN meeting July 2015 (L. Cox)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>92A11579-37EB-4CB1-A7D3-BAE31B1B052E</gtr:id><gtr:impact>Scientific presentation at Oxford Ageing Network meeting; outcome = agreed several collaborations and in discussion with possible industrial funders</gtr:impact><gtr:outcomeId>56db3075a16720.99224570</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Career Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3C572B18-931B-494B-9F3B-77C93B79B799</gtr:id><gtr:impact>A career talk to students and post-docs involving working in the USA</gtr:impact><gtr:outcomeId>58c914a5493b36.82757651</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Science Festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EFE0C6C9-16F7-4250-910D-67D13495B740</gtr:id><gtr:impact>Oxford Science Festival</gtr:impact><gtr:outcomeId>58b4a427934687.74738334</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC case award with GSK</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/P504373/1</gtr:fundingRef><gtr:id>CB619978-BE54-4901-A519-B6FCA9C7CFCC</gtr:id><gtr:outcomeId>58c93d2a587553.57750573</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Academic collaboration with commercial company</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>Amway</gtr:fundingOrg><gtr:id>70F58513-8F97-4400-B4DB-BB2D42650974</gtr:id><gtr:outcomeId>58a1d8366a0e85.04805655</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2017-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6900</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Proximity to Discovery Award</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B587FDBE-EB7E-4C0F-94B9-0C8070EAD142</gtr:id><gtr:outcomeId>56d568acd08bd0.35096757</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Senior Investigator Award</gtr:department><gtr:description>Investigator Award</gtr:description><gtr:end>2021-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>93BAE1D7-B242-413C-A6C6-4CB5D6C09707</gtr:id><gtr:outcomeId>56cf48d4a39559.19849475</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We have developed a potential test for T cell lymphoma which may have future theraeutic relevance.</gtr:description><gtr:grantRef>MC_PC_14131</gtr:grantRef><gtr:id>84B43DE6-B6A0-4934-B573-E0962CBAF14F</gtr:id><gtr:impact>Academic work continues in order to validate the technology. Commercial interactions currently under negotiation.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>58c2e2f75d13c8.70883849</gtr:outcomeId><gtr:patentId>WO2016/051205A1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Development of a test for T celllymphoma/leukaemia</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DE80833D-8261-4BF1-9510-876DC4A1D81C</gtr:id><gtr:title>Expanded GAA repeats impair FXN gene expression and reposition the FXN locus to the nuclear lamina in single cells.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/162c082c41f7e392443803bc1262bde4"><gtr:id>162c082c41f7e392443803bc1262bde4</gtr:id><gtr:otherNames>Silva AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>58c9152fb5e561.54901335</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF1CC55B-68D2-4D7D-8EC4-3B638AB714A4</gtr:id><gtr:title>CalQuo: automated, simultaneous single-cell and population-level quantification of global intracellular Ca2+ responses.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40fa74c28f49eec2ad36195d5e4c36b3"><gtr:id>40fa74c28f49eec2ad36195d5e4c36b3</gtr:id><gtr:otherNames>Fritzsche M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c915913a48a5.44874653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C81298C5-8E47-48FF-8D6E-6FF6E7604551</gtr:id><gtr:title>Assessing similarity to primary tissue and cortical layer identity in induced pluripotent stem cell-derived cortical neurons through single-cell transcriptomics.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32940939798776e174a016529546b916"><gtr:id>32940939798776e174a016529546b916</gtr:id><gtr:otherNames>Handel AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>58c914ffe62af2.19018078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69FDE2AF-A160-4FD8-8CF1-A6D09E1798E1</gtr:id><gtr:title>Studying epigenomics in single cells: what is feasible and what can we learn?</gtr:title><gtr:parentPublicationTitle>Epigenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6951a04aa0c935290484392c1117ca4"><gtr:id>e6951a04aa0c935290484392c1117ca4</gtr:id><gtr:otherNames>Wills QF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-192X</gtr:issn><gtr:outcomeId>56ab581c195825.74271542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C1D9226-5A5B-4343-B8DC-AF495B76B636</gtr:id><gtr:title>Statistical approaches and software for clustering islet cell functional heterogeneity.</gtr:title><gtr:parentPublicationTitle>Islets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6951a04aa0c935290484392c1117ca4"><gtr:id>e6951a04aa0c935290484392c1117ca4</gtr:id><gtr:otherNames>Wills QF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1938-2014</gtr:issn><gtr:outcomeId>58c914b7093586.14882743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2813B376-EA60-465B-8F4E-CB170B5418C0</gtr:id><gtr:title>The nature and nurture of cell heterogeneity: accounting for macrophage gene-environment interactions with single-cell RNA-Seq.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6951a04aa0c935290484392c1117ca4"><gtr:id>e6951a04aa0c935290484392c1117ca4</gtr:id><gtr:otherNames>Wills QF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>58c913e2567c09.82357030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3032A9A2-4678-4106-8740-0B7D902E16DC</gtr:id><gtr:title>Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a153ccf6d3e6dd4a10a5fe993d848d64"><gtr:id>a153ccf6d3e6dd4a10a5fe993d848d64</gtr:id><gtr:otherNames>Psaila B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58b5449d949b76.96389303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BE3EBAB-DCF9-438C-B5AF-C326A658CC0F</gtr:id><gtr:title>Order Under Uncertainty: Robust Differential Expression Analysis Using Probabilistic Models for Pseudotime Inference.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8e546acd004a82778811bdffc84f83b"><gtr:id>a8e546acd004a82778811bdffc84f83b</gtr:id><gtr:otherNames>Campbell KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>58c9143c456de3.93059324</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5320FD10-CA23-48C3-837D-80D7A90F6F83</gtr:id><gtr:title>Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a2a6a343c9659ab8cd4d98f2fe5e8ed"><gtr:id>8a2a6a343c9659ab8cd4d98f2fe5e8ed</gtr:id><gtr:otherNames>McCarthy DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>58c913cab2fd85.50112816</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9245E8CD-A161-47BD-AAF8-5E9E8AAAC79F</gtr:id><gtr:title>pcaReduce: hierarchical clustering of single cell transcriptional profiles.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7089b936d7c291788c6b07fcaf4c97b"><gtr:id>a7089b936d7c291788c6b07fcaf4c97b</gtr:id><gtr:otherNames>?urauskiene J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>58c9146c614899.57707701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>730F2FD2-EFDA-4E3F-BFA8-3BCE24B35A1D</gtr:id><gtr:title>ZIFA: Dimensionality reduction for zero-inflated single-cell gene expression analysis.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d83a935cb3bd7075fd38526fbaa8a13"><gtr:id>7d83a935cb3bd7075fd38526fbaa8a13</gtr:id><gtr:otherNames>Pierson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58c915559e0a00.28352651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1646BF72-C0A9-4D99-8BB6-96C31D5C7328</gtr:id><gtr:title>Application of single-cell genomics in cancer: promise and challenges.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6951a04aa0c935290484392c1117ca4"><gtr:id>e6951a04aa0c935290484392c1117ca4</gtr:id><gtr:otherNames>Wills QF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56ab5834284d91.66364025</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_14131</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C4255A20-7C03-4147-BA26-8D72C9457F1C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Health Uncodeable</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>06E85C67-BEDD-4C93-990D-B74FCF876924</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Research Uncodeable</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>